This is distinct from the classical FcγR-mediated macrophage phagocytosis, which explains why anti-GPIbα-mediated ITP is resistant to FcγR pathways-targeted treatments. The gene discussed is FCGR2A; the disease is autoimmune thrombocytopenic purpura.